Breast cancer risk and hormone replacement therapy among BRCA carriers after risk-reducing salpingo-oophorectomy.
Sign Up to like & getrecommendations! Published in 2021 at "European journal of cancer"
DOI: 10.1016/j.ejca.2021.02.007
Abstract: INTRODUCTION BRCA1/BRCA2 mutation carriers often undergo risk-reducing salpingo-oophorectomy (RRSO) before natural menopause, raising the issue of hormonal replacement treatment (HRT) use. There is conflicting evidence on the effect of HRT on breast cancer (BC) risk,… read more here.
Keywords: risk; risk reducing; salpingo oophorectomy; hrt ... See more keywords
Impact of risk-reducing salpingo-oophorectomy in premenopausal women
Sign Up to like & getrecommendations! Published in 2017 at "Climacteric"
DOI: 10.1080/13697137.2017.1285879
Abstract: Abstract Objectives: To describe implications of premenopausal risk-reducing salpingo-oophorectomy (RRSO) on quality of life, endocrine symptoms, sexual function, osteoporosis, cardiovascular health, metabolic syndrome, cognitive impairment and safety of hormone replacement therapy. Methods: We searched the… read more here.
Keywords: premenopausal women; risk; risk reducing; impact risk ... See more keywords
Does anti-Müllerian hormone predict change in menopausal symptoms following risk-reducing salpingo-oophorectomy? A prospective observational study
Sign Up to like & getrecommendations! Published in 2018 at "Climacteric"
DOI: 10.1080/13697137.2018.1512965
Abstract: Abstract Objectives: The aim of this study was to investigate whether serum anti-Müllerian hormone (AMH) predicts symptom burden after risk-reducing salpingo-oophorectomy (RRSO) in order to individualize counseling. Methods: Patient-reported menopausal symptoms, sexual functioning, and psychological… read more here.
Keywords: risk; risk reducing; anti llerian; change ... See more keywords
Safety of hormone replacement therapy following risk-reducing salpingo-oophorectomy: systematic review of literature and guidelines
Sign Up to like & getrecommendations! Published in 2019 at "Climacteric"
DOI: 10.1080/13697137.2019.1582622
Abstract: Abstract Background: Women at high risk to develop ovarian cancer opt for risk-reducing salpingo-oophorectomy (RRSO) to reduce the risk by 80–96%. RRSO leads to a direct onset of menopause in premenopausal women. Hormone replacement therapy… read more here.
Keywords: risk; risk reducing; salpingo oophorectomy; rrso ... See more keywords
Preoperative screening endometrial cytology discovered incidental gynaecological malignancy in two patients undergoing risk-reducing salpingo-oophorectomy
Sign Up to like & getrecommendations! Published in 2023 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-254484
Abstract: Pelvic ultrasonography and measurement of serum cancer antigen 125 (CA-125) are recommended for preoperative evaluation before performing risk-reducing salpingo-oophorectomy (RRSO). We report our experience with two patients in whom an incidental gynaecological malignancy was found… read more here.
Keywords: endometrial cytology; preoperative screening; risk reducing; reducing salpingo ... See more keywords
Pathologic findings at risk-reducing salpingo-oophorectomy in germline BRCA mutation carriers: Optimal age of bilateral RRSO.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e13046
Abstract: e13046Background: Most BRCA1/2 carriers do not undergo risk-reducing salpingo-oophorectomy (RRSO) by the recommended age of 40. Methods: We retrospectively reviewed breast cancer patients identified as BRCA mutation carriers who underwent RRSO at Asan Medical Center,… read more here.
Keywords: risk reducing; salpingo oophorectomy; age; rrso ... See more keywords